DOI: 10.1158/1055-9965.epi-07-0672. Lack of Association between Serum Levels of 25-Hydroxyvitamin D and the Subsequent Risk of Prostate Cancer in Finnish Men

Lack of Association between Serum Levels of 25-Hydroxyvitamin D and the Subsequent Risk of Prostate Cancer in Finnish Men

10.1158/1055-9965.epi-07-0672

Crossref journal-article

American Association for Cancer Research (AACR)

Cancer Epidemiology, Biomarkers & Prevention (1086)

Bibliography

Faupel-Badger, J. M., Diaw, L., Albanes, D., Virtamo, J., Woodson, K., & Tangrea, J. A. (2007). Lack of Association between Serum Levels of 25-Hydroxyvitamin D and the Subsequent Risk of Prostate Cancer in Finnish Men. Cancer Epidemiology, Biomarkers & Prevention, 16(12), 2784â2786.

Authors 6

Jessica M. Faupel-Badger (first)
Lena Diaw (additional)
Demetrius Albanes (additional)
Jarmo Virtamo (additional)
Karen Woodson (additional)
Joseph A. Tangrea (additional)

References 17 Referenced 48

Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 1992;70:2861–9. (10.1002/1097-0142(19921215)70:12<2861::AID-CNCR2820701224>3.0.CO;2-G)
Schwartz GG, Hanchette CL. UV, latitude, and spatial trends in prostate cancer mortality: all sunlight is not the same (United States). Cancer Causes Control 2006;17:1091–101. (10.1007/s10552-006-0050-6)
Vercelli M, Quaglia A, Marani E, Parodi S. Prostate cancer incidence and mortality trends among elderly and adult Europeans. Crit Rev Oncol Hematol 2000;35:133–44. (10.1016/S1040-8428(99)00067-0)
Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 2005;16:83–95. (10.1007/s10552-004-1661-4)
Schwartz GG. Vitamin D and the epidemiology of prostate cancer. Semin Dial 2005;18:276–89. (10.1111/j.1525-139X.2005.18403.x)
Schwartz GG, Wang MH, Zang M, Singh RK, Siegal GP. 1 α,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol Biomarkers Prev 1997;6:727–32.
Barreto AM, Schwartz GG, Woodruff R, Cramer SD. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiol Biomarkers Prev 2000;9:265–70.
Nomura AM, Stemmermann GN, Lee J, et al. Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States). Cancer Causes Control 1998;9:425–32. (10.1023/A:1008875819232)
Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 2000;11:847–52. (10.1023/A:1008923802001)
Gann PH, Ma J, Hennekens CH, et al. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev 1996;5:121–6.
Li H, Stampfer MJ, Hollis JB, et al. A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor Polymorphisms, and Prostate Cancer. PLoS Med 2007;4:e103. (10.1371/journal.pmed.0040103)
Ma J, Stampfer MJ, Gann PH, et al. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiol Biomarkers Prev 1998;7:385–90.
Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 2004;15:255–65. (10.1023/B:CACO.0000024245.24880.8a)
Tuohimaa P, Tenkanen L, Ahonen M, et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 2004;108:104–8. (10.1002/ijc.11375)
The α-Tocopherol, β-Carotene Cancer Prevention Study Group. The effect of vitamin E and β carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029–35. (10.1056/NEJM199404143301501)
The ATBC Cancer Prevention Study Group. The α-tocopherol, β-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 1994;4:1–10. (10.1016/1047-2797(94)90036-1)
Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998;90:440–6. (10.1093/jnci/90.6.440)

Dates

Type	When
Created	17 years, 8 months ago (Dec. 17, 2007, 10:51 a.m.)
Deposited	3 years, 2 months ago (June 10, 2022, 7:01 a.m.)
Indexed	1 year, 2 months ago (June 7, 2024, 7:16 a.m.)
Issued	17 years, 9 months ago (Dec. 1, 2007)
Published	17 years, 9 months ago (Dec. 1, 2007)
Published Online	17 years, 8 months ago (Dec. 17, 2007)
Published Print	17 years, 9 months ago (Dec. 1, 2007)

Funders 0

None

BibTeX

@article{Faupel_Badger_2007, title={Lack of Association between Serum Levels of 25-Hydroxyvitamin D and the Subsequent Risk of Prostate Cancer in Finnish Men}, volume={16}, ISSN={1538-7755}, url={http://dx.doi.org/10.1158/1055-9965.epi-07-0672}, DOI={10.1158/1055-9965.epi-07-0672}, number={12}, journal={Cancer Epidemiology, Biomarkers & Prevention}, publisher={American Association for Cancer Research (AACR)}, author={Faupel-Badger, Jessica M. and Diaw, Lena and Albanes, Demetrius and Virtamo, Jarmo and Woodson, Karen and Tangrea, Joseph A.}, year={2007}, month=dec, pages={2784–2786} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2024,
        6,
        7
      ]
    ],
    "date-time": "2024-06-07T11:16:19Z",
    "timestamp": 1717758979860
  },
  "reference-count": 17,
  "publisher": "American Association for Cancer Research (AACR)",
  "issue": "12",
  "content-domain": {
    "domain": [
      "aacrjournals.org"
    ],
    "crossmark-restriction": true
  },
  "published-print": {
    "date-parts": [
      [
        2007,
        12,
        1
      ]
    ]
  },
  "DOI": "10.1158/1055-9965.epi-07-0672",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2007,
        12,
        17
      ]
    ],
    "date-time": "2007-12-17T15:51:00Z",
    "timestamp": 1197906660000
  },
  "page": "2784-2786",
  "update-policy": "http://dx.doi.org/10.1158/crossmark_policy",
  "source": "Crossref",
  "is-referenced-by-count": 48,
  "title": "Lack of Association between Serum Levels of 25-Hydroxyvitamin D and the Subsequent Risk of Prostate Cancer in Finnish Men",
  "prefix": "10.1158",
  "volume": "16",
  "author": [
    {
      "given": "Jessica M.",
      "family": "Faupel-Badger",
      "sequence": "first",
      "affiliation": [
        {
          "name": "1Cancer Prevention Fellowship Program, Division of Cancer Prevention and Mammary Biology and Tumorigenesis Laboratory and"
        }
      ]
    },
    {
      "given": "Lena",
      "family": "Diaw",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "2Cancer Genetics Branch, Center for Cancer Research,"
        }
      ]
    },
    {
      "given": "Demetrius",
      "family": "Albanes",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "3Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, and"
        }
      ]
    },
    {
      "given": "Jarmo",
      "family": "Virtamo",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "5Department of Health Promotion and Chronic Disease Prevention, National Public Health Institute, Helsinki, Finland"
        }
      ]
    },
    {
      "given": "Karen",
      "family": "Woodson",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "2Cancer Genetics Branch, Center for Cancer Research,"
        }
      ]
    },
    {
      "given": "Joseph A.",
      "family": "Tangrea",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "4Prostate and Urologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland and"
        }
      ]
    }
  ],
  "member": "1086",
  "published-online": {
    "date-parts": [
      [
        2007,
        12,
        17
      ]
    ]
  },
  "reference": [
    {
      "key": "2022061001543333700_BIB1",
      "doi-asserted-by": "crossref",
      "unstructured": "Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer\u20081992;70:2861\u20139.",
      "DOI": "10.1002/1097-0142(19921215)70:12<2861::AID-CNCR2820701224>3.0.CO;2-G"
    },
    {
      "key": "2022061001543333700_BIB2",
      "doi-asserted-by": "crossref",
      "unstructured": "Schwartz GG, Hanchette CL. UV, latitude, and spatial trends in prostate cancer mortality: all sunlight is not the same (United States). Cancer Causes Control\u20082006;17:1091\u2013101.",
      "DOI": "10.1007/s10552-006-0050-6"
    },
    {
      "key": "2022061001543333700_BIB3",
      "doi-asserted-by": "crossref",
      "unstructured": "Vercelli M, Quaglia A, Marani E, Parodi S. Prostate cancer incidence and mortality trends among elderly and adult Europeans. Crit Rev Oncol Hematol\u20082000;35:133\u201344.",
      "DOI": "10.1016/S1040-8428(99)00067-0"
    },
    {
      "key": "2022061001543333700_BIB4",
      "doi-asserted-by": "crossref",
      "unstructured": "Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control\u20082005;16:83\u201395.",
      "DOI": "10.1007/s10552-004-1661-4"
    },
    {
      "key": "2022061001543333700_BIB5",
      "doi-asserted-by": "crossref",
      "unstructured": "Schwartz GG. Vitamin D and the epidemiology of prostate cancer. Semin Dial\u20082005;18:276\u201389.",
      "DOI": "10.1111/j.1525-139X.2005.18403.x"
    },
    {
      "key": "2022061001543333700_BIB6",
      "unstructured": "Schwartz GG, Wang MH, Zang M, Singh RK, Siegal GP. 1 \u03b1,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol Biomarkers Prev\u20081997;6:727\u201332."
    },
    {
      "key": "2022061001543333700_BIB7",
      "unstructured": "Barreto AM, Schwartz GG, Woodruff R, Cramer SD. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiol Biomarkers Prev\u20082000;9:265\u201370."
    },
    {
      "key": "2022061001543333700_BIB8",
      "doi-asserted-by": "crossref",
      "unstructured": "Nomura AM, Stemmermann GN, Lee J, et al. Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States). Cancer Causes Control\u20081998;9:425\u201332.",
      "DOI": "10.1023/A:1008875819232"
    },
    {
      "key": "2022061001543333700_BIB9",
      "doi-asserted-by": "crossref",
      "unstructured": "Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control\u20082000;11:847\u201352.",
      "DOI": "10.1023/A:1008923802001"
    },
    {
      "key": "2022061001543333700_BIB10",
      "unstructured": "Gann PH, Ma J, Hennekens CH, et al. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev\u20081996;5:121\u20136."
    },
    {
      "key": "2022061001543333700_BIB11",
      "doi-asserted-by": "crossref",
      "unstructured": "Li H, Stampfer MJ, Hollis JB, et al. A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor Polymorphisms, and Prostate Cancer. PLoS Med\u20082007;4:e103.",
      "DOI": "10.1371/journal.pmed.0040103"
    },
    {
      "key": "2022061001543333700_BIB12",
      "unstructured": "Ma J, Stampfer MJ, Gann PH, et al. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiol Biomarkers Prev\u20081998;7:385\u201390."
    },
    {
      "key": "2022061001543333700_BIB13",
      "doi-asserted-by": "crossref",
      "unstructured": "Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control\u20082004;15:255\u201365.",
      "DOI": "10.1023/B:CACO.0000024245.24880.8a"
    },
    {
      "key": "2022061001543333700_BIB14",
      "doi-asserted-by": "crossref",
      "unstructured": "Tuohimaa P, Tenkanen L, Ahonen M, et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer\u20082004;108:104\u20138.",
      "DOI": "10.1002/ijc.11375"
    },
    {
      "key": "2022061001543333700_BIB15",
      "doi-asserted-by": "crossref",
      "unstructured": "The \u03b1-Tocopherol, \u03b2-Carotene Cancer Prevention Study Group. The effect of vitamin E and \u03b2 carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med\u20081994;330:1029\u201335.",
      "DOI": "10.1056/NEJM199404143301501"
    },
    {
      "key": "2022061001543333700_BIB16",
      "doi-asserted-by": "crossref",
      "unstructured": "The ATBC Cancer Prevention Study Group. The \u03b1-tocopherol, \u03b2-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol\u20081994;4:1\u201310.",
      "DOI": "10.1016/1047-2797(94)90036-1"
    },
    {
      "key": "2022061001543333700_BIB17",
      "doi-asserted-by": "crossref",
      "unstructured": "Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with \u03b1-tocopherol and \u03b2-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst\u20081998;90:440\u20136.",
      "DOI": "10.1093/jnci/90.6.440"
    }
  ],
  "container-title": "Cancer Epidemiology, Biomarkers &amp; Prevention",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://aacrjournals.org/cebp/article-pdf/16/12/2784/1940433/2784.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "syndication"
    },
    {
      "URL": "https://aacrjournals.org/cebp/article-pdf/16/12/2784/1940433/2784.pdf",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2022,
        6,
        10
      ]
    ],
    "date-time": "2022-06-10T11:01:53Z",
    "timestamp": 1654858913000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://aacrjournals.org/cebp/article/16/12/2784/260054/Lack-of-Association-between-Serum-Levels-of-25"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2007,
        12,
        1
      ]
    ]
  },
  "references-count": 17,
  "journal-issue": {
    "issue": "12",
    "published-online": {
      "date-parts": [
        [
          2007,
          12,
          17
        ]
      ]
    },
    "published-print": {
      "date-parts": [
        [
          2007,
          12,
          1
        ]
      ]
    }
  },
  "URL": "http://dx.doi.org/10.1158/1055-9965.EPI-07-0672",
  "relation": {},
  "ISSN": [
    "1055-9965",
    "1538-7755"
  ],
  "subject": [],
  "published": {
    "date-parts": [
      [
        2007,
        12,
        1
      ]
    ]
  }
}